跳至主要内容
临床试验/NCT05883605
NCT05883605已完成不适用

Clinical Validation of the Wrist Blood Pressure Measuring Device Combei BP 880 W for Home Use According to "the Universal" Standard (AAMI/ESH/ISO)" in the General Population

International Society for Vascular Health2 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2023年1月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
85
试验地点
2
主要终点
Accuracy of blood pressure measurement

研究概览

简要总结

Clinical validation of the wrist blood pressure measuring device Combei BP 880 W for home use according to "the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO)" in the general population.

详细描述

Members of the AAMI, ESH and ISO committees achieved a consensus on an optimal validation standard and agreed on a single protocol for the validation of BP measuring devices that will replace all previous ones.

Therefore, the Association for the Advancement of Medical Instrumentation / European Society of Hypertension / International Organization for Standardization Universal Standard (AAMI/ESH/ISO 81060-2:2018) is now considered as the standard protocol for the validation of non-invasive blood pressure measuring device.

This study aims to demonstrate that the Combei BP 880 W wrist device fulfills the requirements of the new protocol of clinical validation and its Amendment 1, 2020-01 for limb circumference distribution criteria.

this is a monocentric, prospective, non-randomized, non-interventional, cross-study.

Combei BP 880 W wrist device (Sphygmomanometer Under Test, SUT). The reference device is the mercury sphygmomanometer The primary objective of the study is to assess the accuracy of the automatic oscillometric BP measuring device at the wrist level, the Combei BP 880 W, in the general population, following AAMI/ESH/ISO 81060-2:2018 protocol and its Amendment 1, 2020-01 for limb circumference distribution criteria.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient older than 12 years;
  • Patient who signed the informed consent form;
  • Patient followed-up at site (in-patient or out-patient);
  • Patient with wrist circumference between 12.5 and 21.5 cm*. *in accordance with the Indications For Use of the Combei BP 880 W device.

排除标准

  • Patient unable to give a consent or understand properly protocol information;
  • Patient suffering from arrhythmia;
  • Patient with poor quality of Korotkov sounds;
  • Patient for whom K5 sounds are absent.

结局指标

主要结局

Accuracy of blood pressure measurement

时间窗: Subject will participate to only one session of measurement. The duration of one session is about 45 minutes.

differences \< than 5 +/- 8 mmHg according to the protocol by comparison to the gold standard (mercury sphygmomanometer)

次要结局

  • differences between the tested device and the gold standard (mercury sphygmomanometer according to the baseline blood pressure and to the wrist circumference(Subject will participate only one time to the study. one session of blood pressure measurement will be performed. the duration of one session is about 45 minutes)

研究者

发起方
International Society for Vascular Health
申办方类型
Other
责任方
Principal Investigator
主要研究者

Catherine DOGNON HADDAD

Professor Roland Asmar

International Society for Vascular Health

研究点 (2)

Loading locations...

相似试验

Clinical Validation of The Combei BP 880 W | 临床试验